MEDS700 is a blood-brain barrier permeable inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an IC50 of 1.5 nM. MEDS700 induces apoptosis and differentiation, and inhibits proliferation of cancer cells. MEDS700 can be used in research on acute myeloid leukemia and other conditions[1].
Molekulargewicht:
495.37
CAS Nummer:
[2770979-81-0]
Formel:
C23H15F6N3O3
Target-Kategorie:
Apoptosis,Dihydroorotate Dehydrogenase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
